0000950170-23-070835.txt : 20231215 0000950170-23-070835.hdr.sgml : 20231215 20231215173117 ACCESSION NUMBER: 0000950170-23-070835 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Provost Miriam CENTRAL INDEX KEY: 0001773663 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38891 FILM NUMBER: 231491513 MAIL ADDRESS: STREET 1: 2000 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc. CENTRAL INDEX KEY: 0001756262 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 9785520900 MAIL ADDRESS: STREET 1: 200 MINUTEMAN ROAD CITY: ANDOVER STATE: MA ZIP: 01810 4 1 ownership.xml 4 X0508 4 2023-12-13 0001756262 TransMedics Group, Inc. TMDX 0001773663 Provost Miriam C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD ANDOVER MA 01810 false true false false VP, Global Regulatory Affairs false Common Stock 2023-12-13 4 M false 415 16.14 A 24026 D Common Stock 2023-12-13 4 S false 206 75.10 D 23820 D Common Stock 2023-12-13 4 M false 1632 66.10 A 25452 D Common Stock 2023-12-13 4 S false 1509 75.10 D 23943 D Common Stock 2023-12-13 4 M false 3597 38.46 A 27540 D Common Stock 2023-12-13 4 S false 2407 75.10 D 25133 D Common Stock 2023-12-15 4 G false 1785 0.00 D 23348 D Stock Option (Right to Buy) 16.14 2023-12-13 4 M false 415 0.00 D 2030-02-27 Common Stock 415 7811 D Stock Option (Right to Buy) 66.10 2023-12-13 4 M false 1632 0.00 D 2033-02-20 Common Stock 1632 7073 D Stock Option (Right to Buy) 38.46 2023-12-13 4 M false 3597 0.00 D 2031-02-24 Common Stock 3597 7813 D The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options. On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes. Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. By: /s/ Stephen Gordon, Attorney-in-Fact 2023-12-15